Insiders · Profile

Sniecinski Megan

Chief Business Officer at BIOCRYST PHARMACEUTICALS. Filing since 18 Nov 2019. CIK 0001781480

Company
Date
Role
Action
Shares
Amount
Of holding
18 Nov 2019
Chief Business Officer
Bought
45,000
$65.25K
opened
1 decision on file.